140 related articles for article (PubMed ID: 34213370)
1. MRI Volumetrics and Image Texture Analysis in Assessing Systemic Treatment Response in Extra-Abdominal Desmoid Fibromatosis.
Subhawong TK; Feister K; Sweet K; Alperin N; Kwon D; Rosenberg A; Trent J; Wilky BA
Radiol Imaging Cancer; 2021 Jul; 3(4):e210016. PubMed ID: 34213370
[TBL] [Abstract][Full Text] [Related]
2. Progressive Desmoid Tumor: Radiomics Compared With Conventional Response Criteria for Predicting Progression During Systemic Therapy-A Multicenter Study by the French Sarcoma Group.
Crombé A; Kind M; Ray-Coquard I; Isambert N; Chevreau C; André T; Lebbe C; Cesne AL; Bompas E; Piperno-Neumann S; Saada E; Bouhamama A; Blay JY; Italiano A;
AJR Am J Roentgenol; 2020 Dec; 215(6):1539-1548. PubMed ID: 32991215
[No Abstract] [Full Text] [Related]
3. Desmoid fibromatosis: MRI features of response to systemic therapy.
Sheth PJ; Del Moral S; Wilky BA; Trent JC; Cohen J; Rosenberg AE; Temple HT; Subhawong TK
Skeletal Radiol; 2016 Oct; 45(10):1365-73. PubMed ID: 27502790
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging patterns of tumor response to chemotherapy in desmoid-type fibromatosis.
Zanchetta E; Ciniselli CM; Bardelli A; Colombo C; Stacchiotti S; Baldi GG; Provenzano S; Bertulli R; Bini F; Casale A; Greco FG; Ferrari A; Verderio P; Fiore M; Gronchi A; Casali PG; Morosi C; Palassini E
Cancer Med; 2021 Jul; 10(13):4356-4365. PubMed ID: 34102009
[TBL] [Abstract][Full Text] [Related]
5. MRI T2 mapping assessment of T2 relaxation time in desmoid tumors as a quantitative imaging biomarker of tumor response: preliminary results.
Souza FF; D'Amato G; Jonczak EE; Costa P; Trent JC; Rosenberg AE; Yechieli R; Temple HT; Pattany P; Subhawong TK
Front Oncol; 2023; 13():1286807. PubMed ID: 38188297
[TBL] [Abstract][Full Text] [Related]
6. Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI.
Ingley KM; Burtenshaw SM; Theobalds NC; White LM; Blackstein ME; Gladdy RA; Thipphavong S; Gupta AA
Cancer Med; 2019 Sep; 8(11):5047-5057. PubMed ID: 31301110
[TBL] [Abstract][Full Text] [Related]
7. MR-guided focused ultrasound therapy of extra-abdominal desmoid tumors: a multicenter retrospective study of 105 patients.
Düx DM; Baal JD; Bitton R; Chen J; Brunsing RL; Sheth VR; Rosenberg J; Kim K; Ozhinsky E; Avedian R; Ganjoo K; Bucknor M; Dobrotwir A; Ghanouni P
Eur Radiol; 2024 Feb; 34(2):1137-1145. PubMed ID: 37615768
[TBL] [Abstract][Full Text] [Related]
8. Desmoid-type fibromatosis: Tumour response assessment using magnetic resonance imaging signal and size criteria.
Zhu HC; Li XT; Ji WY; Li S; Sun YS
Clin Imaging; 2020 Dec; 68():111-120. PubMed ID: 32590270
[TBL] [Abstract][Full Text] [Related]
9. Correlation between tumor growth and hormonal therapy with MR signal characteristics of desmoid-type fibromatosis: A preliminary study.
Gondim Teixeira PA; Chanson A; Verhaeghe JL; Lecocq S; Louis M; Hossu G; Blum A
Diagn Interv Imaging; 2019 Jan; 100(1):47-55. PubMed ID: 30037746
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Therapy Response to Transarterial Radioembolization for Liver Metastases by Means of Post-treatment MRI-Based Texture Analysis.
Reimer RP; Reimer P; Mahnken AH
Cardiovasc Intervent Radiol; 2018 Oct; 41(10):1545-1556. PubMed ID: 29881933
[TBL] [Abstract][Full Text] [Related]
11. [Value of dual-energy CT-based volumetric iodine-uptake in the evaluation of chemotherapy efficacy in advanced gastric cancer].
Chen LF; Fu GZ; Huang DP; Man Y; Jin Y; Dong QT; Huang YB; Chen YC; Wang HQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Oct; 22(10):977-983. PubMed ID: 31630497
[No Abstract] [Full Text] [Related]
12. Evidence-based MR imaging follow-up strategy for desmoid-type fibromatosis.
Gondim Teixeira PA; Biouichi H; Abou Arab W; Rios M; Sirveaux F; Hossu G; Blum A
Eur Radiol; 2020 Feb; 30(2):895-902. PubMed ID: 31468156
[TBL] [Abstract][Full Text] [Related]
13. Initial Active Surveillance Strategy for Patients with Peripheral Sporadic Primary Desmoid-Type Fibromatosis: A Multicentric Phase II Observational Trial.
Bonvalot S; Cozic N; Le Cesne A; Blay JY; Penel N; Fau M; Chevreau C; Anract P; Waast D; Laurence V; Watson S; Duffaud F; Gouin F; Taieb S; Kind M; Lam L
Ann Surg Oncol; 2023 Dec; 30(13):8653-8659. PubMed ID: 37777684
[TBL] [Abstract][Full Text] [Related]
14. [Imaging manifestations and pathologic features of soft tissue desmoid-type fibromatosis].
Liu QY; Chen JY; Liang BL; Li HG; Gao M; Lin XF
Ai Zheng; 2008 Dec; 27(12):1287-92. PubMed ID: 19079995
[TBL] [Abstract][Full Text] [Related]
15. Adapted Choi response criteria for prediction of clinical outcome in locally advanced gastric cancer patients following preoperative chemotherapy.
Liu K; Li G; Fan C; Zhou C; Li J
Acta Radiol; 2012 Mar; 53(2):127-34. PubMed ID: 22156007
[TBL] [Abstract][Full Text] [Related]
16. Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis--an EORTC STBSG and ROG study (EORTC 62991-22998).
Keus RB; Nout RA; Blay JY; de Jong JM; Hennig I; Saran F; Hartmann JT; Sunyach MP; Gwyther SJ; Ouali M; Kirkpatrick A; Poortmans PM; Hogendoorn PCW; van der Graaf WTA
Ann Oncol; 2013 Oct; 24(10):2672-2676. PubMed ID: 23868907
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance-guided focused ultrasound treatment of extra-abdominal desmoid tumors: a retrospective multicenter study.
Ghanouni P; Dobrotwir A; Bazzocchi A; Bucknor M; Bitton R; Rosenberg J; Telischak K; Busacca M; Ferrari S; Albisinni U; Walters S; Gold G; Ganjoo K; Napoli A; Pauly KB; Avedian R
Eur Radiol; 2017 Feb; 27(2):732-740. PubMed ID: 27147222
[TBL] [Abstract][Full Text] [Related]
18. Association of MRI T2 Signal Intensity With Desmoid Tumor Progression During Active Observation: A Retrospective Cohort Study.
Cassidy MR; Lefkowitz RA; Long N; Qin LX; Kirane A; Sbaity E; Hameed M; Coit DG; Brennan MF; Singer S; Crago AM
Ann Surg; 2020 Apr; 271(4):748-755. PubMed ID: 30418203
[TBL] [Abstract][Full Text] [Related]
19. Undervaluation of Radiotherapy for Gross Desmoid Tumors: The Need for Absolute Volume Assessment.
Kim YJ; Song SY; Kim W; Lee J; Ahn JH; Kim JE; Chung HW; Jeong SY; Choi EK
In Vivo; 2021; 35(3):1777-1784. PubMed ID: 33910862
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of apatinib for patients with advanced extremity desmoid fibromatosis: a retrospective study.
Zheng C; Fang J; Wang Y; Zhou Y; Tu C; Min L
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2127-2135. PubMed ID: 33452581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
